132 filings
Page 3 of 7
8-K
i0ob9
21 Aug 08
Lotus Pharmaceuticals Announces Second Quarter 2008 Results
12:00am
EFFECT
yy6urc
25 Jul 08
Notice of effectiveness
12:00am
424B3
gb7q 263tal9k7
25 Jul 08
Prospectus supplement
12:00am
CORRESP
m121ksqxzyc9dbn
23 Jul 08
Correspondence with SEC
12:00am
8-K
8vgjm0ywotp4p d8ab4
17 Jul 08
Entry into a Material Definitive Agreement
12:00am
UPLOAD
31xx5fy
2 Jul 08
Letter from SEC
12:00am
UPLOAD
hrms5ud38 u0l6c
23 Jun 08
Letter from SEC
12:00am
S-1/A
bmxheljwd
20 Jun 08
IPO registration (amended)
12:00am
EFFECT
9hgkqnrrsre onj159j
17 Jun 08
Notice of effectiveness
12:00am
POS AM
jk4x6rzfsid63g1k
16 Jun 08
Prospectus update (post-effective amendment)
12:00am
UPLOAD
v7x94 rl3219wqfvyb
3 Jun 08
Letter from SEC
12:00am
8-K
ddb3bvj6j81oix
30 May 08
Lotus Pharmaceuticals Inc Q1 Earnings Conference Call
12:00am
8-K
qv1hbyid
30 May 08
Lotus Pharmaceuticals, Inc. Obtains Patent and Exclusive Production Rights to Laevo-Bambutero Asthma Treatment
12:00am
8-K
oydwo9g
22 May 08
Results of Operations and Financial Condition
12:00am
10-Q
lfy4d9ewlwj 5h0rhth
20 May 08
Quarterly report
12:00am
NT 10-Q
oqhnkemh
16 May 08
Notice of late quarterly filing
12:00am
CORRESP
0jn5yga70wfrrom4
13 May 08
Correspondence with SEC
12:00am
S-1
owk2g60
13 May 08
IPO registration
12:00am